Cardiff Oncology to Attend Two Upcoming Investor Conferences
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 02 2025
0mins
Source: Globenewswire
Investor Conferences Participation: Cardiff Oncology, Inc. will participate in two investor conferences on October 9, 2025, including a fireside chat at the Piper Sandler Virtual Oncology Symposium and another at the Noble Capital Markets’ Emerging Growth Virtual Equity Conference.
Company Overview: Cardiff Oncology is focused on developing novel cancer therapies through PLK1 inhibition, with its lead asset, onvansertib, being evaluated in various clinical programs targeting multiple cancer types, including metastatic colorectal cancer and pancreatic cancer.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
